Sec. 20-7a. Billing for clinical laboratory services. Cost of diagnostic tests. Financial disclosures to patients.
Sec. 20-7a. Billing for clinical laboratory services. Cost of diagnostic tests. Financial disclosures to patients. (a) Any practitioner of the healing arts who agrees
with any clinical laboratory, either private or hospital, to make payments to such laboratory for individual tests or test series for patients shall disclose on the bills to patients
or third party payors the name of such laboratory, the amount or amounts charged by
such laboratory for individual tests or test series and the amount of his procurement or
processing charge, if any, for each test or test series. Any person who violates the provisions of this section shall be fined not more than one hundred dollars.
(b) Each practitioner of the healing arts who recommends a test to aid in the diagnosis of a patient's physical condition shall, to the extent the practitioner is reasonably
able, inform the patient of the approximate range of costs of such test.
(c) Each practitioner of the healing arts who (1) has an ownership or investment
interest in an entity that provides diagnostic or therapeutic services, or (2) receives
compensation or remuneration for referral of patients to an entity that provides diagnostic or therapeutic services shall disclose such interest to any patient prior to referring
such patient to such entity for diagnostic or therapeutic services and provide reasonable
referral alternatives. Such information shall be verbally disclosed to each patient or shall
be posted in a conspicuous place visible to patients in the practitioner's office. The posted
information shall list the therapeutic and diagnostic services in which the practitioner has
an ownership or investment interest and therapeutic and diagnostic services from which
the practitioner receives compensation or remuneration for referrals and state that alternate referrals will be made upon request. Therapeutic services include physical therapy,
radiation therapy, intravenous therapy and rehabilitation services including physical
therapy, occupational therapy or speech and language pathology, or any combination
of such therapeutic services. This subsection shall not apply to in-office ancillary services. As used in this subsection, "ownership or investment interest" does not include
ownership of investment securities that are purchased by the practitioner on terms available to the general public and are publicly traded; and "entity that provides diagnostic
or therapeutic services" includes services provided by an entity that is within a hospital
but is not owned by the hospital. Violation of this subsection constitutes conduct subject
to disciplinary action under subdivision (6) of subsection (a) of section 19a-17.
(P.A. 73-159; P.A. 91-168; P.A. 92-24; P.A. 05-272, S. 18; P.A. 06-196, S. 246.)
History: P.A. 91-168 added a new Subsec. (b) to require practitioners to inform patients regarding the costs of diagnostic
tests ordered, and added a new Subsec. (c) to require practitioners to make disclosures of financial interests in diagnostic
imaging equipment to patients; P.A. 92-24 amended Subsec. (c) to change disclosure requirements from diagnostic imaging
equipment to diagnostic or therapeutic services or compensation or remuneration for referrals of such services, to explain
verbal and posted disclosure requirements, to add definition of entity which provides diagnostic or therapeutic services,
and to make violation of Subsec. subject to disciplinary action; P.A. 05-272 amended Subsec. (c) by making technical
changes and replacing "speech pathology" with "speech and language pathology"; P.A. 06-196 made technical changes
in Subsec. (c), effective June 7, 2006.